Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality8/10

Arq reports Q2 2026 results with margin expansion and PFAS growth catalysts

Aug 10, 2026, 4:47 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The beat on profitability metrics, margin expansion, and reaffirmed full-year guidance typically drives short-term upside for a small-cap. PFAS PAC potential could compound mid-term value, though liquidity and leverage caveats exist. Historical precedent: earnings-driven re-ratings at mid-caps when guidance is reaffirmed and new product avenues are highlighted.

AI summary

What happened, with direct paths to the underlying reporting

Arq posted $29.9 million in Q2 2026 revenue and 38.5% gross margin, with Adjusted EBITDA of $5.8 million, marking the ninth straight positive quarter. The company reaffirmed 2026 guidance and highlighted PFAS-focused PAC initiatives and ongoing GAC optimization as potential catalysts for 2027 growth, while noting a leaner immediate cash position and moderate debt.

Q2 2026 revenue $29.9M, up 5% YoY. Gross margin 38.5% (+520 bps).
Adjusted EBITDA $5.8M; 9th consecutive quarter of positive EBITDA.
Reaffirms 2026 guidance: $120-125M revenue, $17-20M Adjusted EBITDA.
PFAS PAC initiative progress could lift volumes/margins in 2027.
Red River plant turnaround completed under budget; 2026 capex guidance $8-10M.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.